Sopino, Vicente C.

HRN: 11-26-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/15/2022
11/25/2022
IVT
1.5 G Ivt
Q6 X 4 Days More
Nonhealing Wound, Multiple Myeloma
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: